anti-PD1 treatmentimmune checkpoint therapyTNG260pembrolizumab
…t CoREST inhibition by TNG260 sensitizes STK11-mutant tumors to anti-PD1 treatment. TNG260, in combination with pembrolizumab, is being evaluated …
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 2,101–2,160 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
CREST-21CRS-HIPEC1CSAI1CSD1CSIs1CT1CT angiography1CT-guided percutaneous fibrin glue embolization1CTs1CVVHDF1CYP2C19-guided antiplatelet therapy1Casting1Cervical anesthetic blocks1Cervical epidural steroid injections1Cervical retrolaminar blocks1Cesarean section1Checkpoint inhibitor immunotherapy1Childhood cancer treatment1Chimeric Antigen Receptor (CAR) T cell therapies1Chimeric Antigen Receptor T (CAR T) cell therapies1Chimeric Antigen Receptor T cell therapy1Chimeric antigen receptor (CAR) T -cell therapy1Chimeric antigen receptor (CAR) T therapies1Chimeric antigen receptor (CAR) T therapy1Chimeric antigen receptor (CAR) T treatments1Chimeric antigen receptor (CAR) therapies1Chimeric antigen receptor T (CAR-T) cell therapies1Chimeric antigen receptor natural killer cell (CAR-NK) therapy1Chinese herbal medicine1Chronic pain management1Chuna manual therapy1Chuna therapy1Claudin 18.2-directed therapies1Claudin18.2-specific CAR-T cell therapy1Cognitive remediation therapy1Coil-adjunct embolization1Combined chemoradiotherapy1Compassionate care1Complete revascularisation1Concussion Essentials1Contraceptive technology1Contragestion1Conventional Therapy1Conventional immunosuppressants1Conventional opioid therapy1Corneal endothelial cell therapy1Coronary sinus reducer (CSR) implantation1Corticosteroid re-escalation1Corticosteroids in palliative care1Cranioplasty1Cryoballoon Focal Ablation1Cryoballoon ablation1Curative-intent multimodality treatment1D3 right extended hemicolectomy1DA-EPOCH polychemotherapy1DAE1DAsC-assisted aspiration thrombectomy1DCBA1DCCV1DCE1
Articles mentioning treatments
7,227 articles · page 231 of 603lymphodepleting chemotherapyAGX-148oral head and neck squamous cell carcinomamelanomathyroid cancersolid tumorsProvidence Institutional Review BoardClinicalTrials.gov
…ard and experimental therapies. Patients undergo tumor harvest, lymphodepleting chemotherapy, adoptive transfer of AGX-148 and high-dose IL-2 for one week, …
immunotherapyNanO 2Glioblastoma MultiformeNanO2PaclitaxelTNBCTriple-negative breast cancerDOD GrantBALB/c mice
… experiments, we tested the effect of NanO2 in combination with immunotherapy (IT), chemotherapy (CTX, paclitaxel) or both IT and CTX. BALB/c…
Triplet therapyanthracycline chemotherapyFTY720Flt3LTNBCDoxil D1NCT05029999
…s) as well as by blocking lymphocyte egress with FTY720.Results Triplet therapy significantly delayed tumor progression and extended median sur…
immunotherapyBreast cancerQUICKARRAYS, Inc
…y mapped the TME to identify features potentially predictive of immunotherapy response. FFPE (Formalin-Fixed Paraffin-Embedded) tissue slide …
T-FUSUniversity of Virginiacancerbreast cancerBCNIH DP5OD031846αCD40
…t of CD4+ T cells following rechallenge (figure 2O).Conclusions T-FUS+αCD40 represents a novel paradigm for immunotherapy of BC-capab…
anti-PD-1 therapyPD-1 therapyMD Anderson Cancer CenterKAN-001non-small cell lung cancerNSCLCCRCHUMCanadian Council
… evaluated in the MCA205 murine tumor model in combination with anti-PD-1 therapy. Comparative arms included treatment with FMT from ICI-non-resp…
immune checkpoint blockadeHER2-targeted therapyLeica BiosystemsIndica Labsgastric and gastroesophageal junction (GEJ) adenocarcinomaHER2-amplified colorectal cancerHER2-low breast cancerHER2-positive breast cancer
…, suggesting possible synergy between HER2-targeted therapy and immune checkpoint blockade.In HER2-amplified colorectal cancer, PD-L1 expression and immun…
immunotherapychemotherapyMassachusetts General HospitalMGH Histopathology Research CoreTNBCImmunomedics/GileadSacituzumab govitecantriple-negative breast cancerhuman breast cancer
…ody drug conjugates to activate anti-tumor immunity and enhance immunotherapy response.Acknowledgements We gratefully acknowledge Immunomedic…
Adoptive CTL therapyimmunotherapymelanoma-specificExtramammary Paget’s disease (EMPD)IL-2EMPDmelanomaRadiother Oncolsolid tumorsEBV-related cancers+1 more
…es in solid tumors, yet limited data exist in the EMPD context. Adoptive CTL therapy, which involves the ex vivo expansion and activation of autolog…
ImmunotherapyAzaAzacytidineAMLAcute Myeloid Leukemia
… AML has remained largely unchanged over the last four decades. Immunotherapy is a promising therapy in many cancers including AML. T cell ex…
immunotherapyEwing SarcomaChildren’s Oncology GroupIL1RAP
…on of the immune environment in ES may reveal the blockades for immunotherapy efforts and potential new pathways to be exploited in the futur…